Pay in 4 interest-free payments of $6.24 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Long-term benefits Metformin does not have an FDA approval for cardiovascular protection, but the medication has metabolic benefits
Personalized Dosing with Precision Peptide Genetic Testing The PlexusDx Precision Peptide Genetic Test analyzes GIPR (rs1800437) and FTO (rs9939609) variants that relate to GLP-1 and related signaling pathways
These impacts are especially noticeable in the first four to eight weeks of a patients GLP-1 weight loss journey, leading to issues like constipation, nausea, bloating, vomiting, and other gastrointestinal discomforts
nausea and constipation are most common in the first 2 to 4 weeks
Studies have shown that it can help reduce the risk of serious heart problems, like heart attacks or strokes, for some people
